Procept BioRobotics Q2 revenue beats estimates on HYDROS demand

PROCEPT BioRobotics

04/08/2026 21:31

Overview
Surgical robotics company's Q2 revenue grew 19% yr/yr, beating analyst expectations
Company posted wider net loss and adjusted EBITDA loss due to higher operating expenses
Company reiterated full-year 2026 revenue guidance and expects continued U.S. procedure growth

Outlook
Company reiterates 2026 revenue guidance of $390 mln to $410 mln
Company expects 2026 U.S. procedure volume of 54,000-56,000, up 25%-29% year-on-year
Company sees 2026 adjusted EBITDA loss of $35 mln to $30 mln

Result Drivers
SYSTEM PLACEMENTS - Q2 revenue growth driven by record HYDROS system placements and robust replacement activity
PROCEDURE VOLUME - U.S. procedure volume grew 21% yr/yr, supporting higher handpiece and consumable sales
PRICING AND TARIFF REFUND - Higher average selling prices and a $2.9 mln tariff refund contributed to gross margin improvement

Company press release: ID:nGNX81T1zR

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$94.50 mln
$92.89 mln (14 Analysts)
Q2 Net Loss
 
$26.86 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 7 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"
Wall Street's median 12-month price target for Procept Biorobotics Corp is $29.50, about 60.5% above its August 3 closing price of $18.38

Reuters Recommended Reads
Aug 3 - Inspire Medical Q2 revenue falls less than expected
Aug 4 - UK's Smith+Nephew cuts 2026 revenue view on weak US knee implant demand
Aug 3 - SI-BONE Q2 revenue beats estimates, raises 2026 revenue outlook

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)